Yamane A, Mori T, Suzuki S, Mihara A, Yamazaki R, Aisa Y et al. Risk factors for developing human herpesvirus 6 (HHV-6) reactivation after allogeneic hematopoietic stem cell transplantation and its association with central nervous system disorders. Biol Blood Marrow Transpl. 2007;13:100–6.
Zerr DM, Corey L, Kim HW, Huang M-L, Nguy L, Boeckh M. Clinical outcomes of human herpesvirus 6 reactivation after hematopoietic stem cell transplantation. Clin Infect Dis. 2005;40:932–40.
Ogata M, Satou T, Kadota J, Saito N, Yoshida T, Okumura H et al. Human herpesvirus 6 (HHV-6) reactivation and HHV-6 encephalitis after allogeneic hematopoietic cell transplantation: a multicenter, prospective study. Clin Infect Dis. 2013;57:671–81.
Scheurer ME, Pritchett JC, Amirian ES, Zemke NR, Lusso P, Ljungman P. HHV-6 encephalitis in umbilical cord blood transplantation: a systematic review and meta-analysis. Bone Marrow Transpl. 2013;48:574–80.
Ward KN, Hill JA, Hubacek P, de la Camara R, Crocchiolo R, Einsele H et al. Guidelines from the 2017 European Conference on Infections in Leukaemia for management of HHV-6 infection in patients with hematologic malignancies and after hematopoietic stem cell transplantation. Haematologica. 2019;104:2155–63.
Ogata M, Oshima K, Ikebe T, Takano K, Kanamori H, Kondo T et al. Clinical characteristics and outcome of human herpesvirus-6 encephalitis after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transpl. 2017;52:1563–70.
Ogata M, Fukuda T, Teshima T. Human herpesvirus-6 encephalitis after allogeneic hematopoietic cell transplantation: what we do and do not know. Bone Marrow Transpl. 2015;50:1030–6.
Hill JA. Human herpesvirus 6 in transplant recipients: an update on diagnostic and treatment strategies. Curr Opin Infect Dis. 2019;32:584–90.
Abidi MZ, Hari P, Chen M, Kim S, Battiwala M, Dahi PB et al. Virus detection in the cerebrospinal fluid of hematopoietic stem cell transplant recipients is associated with poor patient outcomes: a CIBMTR contemporary longitudinal study. Bone Marrow Transpl. 2019;54:1354–60.
Miyashita N, Endo T, Onozawa M, Hashimoto D, Kondo T, Fujimoto K et al. Risk factors of human herpesvirus 6 encephalitis/myelitis after allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis 2017;19. https://doi.org/10.1111/tid.12682.
Perruccio K, Sisinni L, Perez-Martinez A, Valentin J, Capolsini I, Massei MS et al. High incidence of early human herpesvirus-6 infection in children undergoing haploidentical manipulated stem cell transplantation for hematologic malignancies. Biol Blood Marrow Transpl. 2018;24:2549–57.
Sisinni L, Gasior M, de Paz R, Querol S, Bueno D, Fernández L et al. Unexpected high incidence of human herpesvirus-6 encephalitis after naive T cell-depleted graft of haploidentical stem cell transplantation in pediatric patients. Biol Blood Marrow Transpl. 2018;24:2316–23.
Greco R, Crucitti L, Noviello M, Racca S, Mannina D, Forcina A et al. Human Herpesvirus 6 Infection Following Haploidentical Transplantation: Immune Recovery and Outcome. Biol Blood Marrow Transpl. 2016;22:2250–5.
Mori Y, Miyamoto T, Nagafuji K, Kamezaki K, Yamamoto A, Saito N et al. High incidence of human herpes virus 6-associated encephalitis/myelitis following a second unrelated cord blood transplantation. Biol Blood Marrow Transpl. 2010;16:1596–602.
Shintaku M, Kaneda D, Tada K, Katano H, Sata T. Human herpes virus 6 encephalomyelitis after bone marrow transplantation: report of an autopsy case. Neuropathology. 2010;30:50–5.
Berzero G, Campanini G, Vegezzi E, Paoletti M, Pichiecchio A, Simoncelli AM et al. Human Herpesvirus 6 Encephalitis in Immunocompetent and Immunocompromised Hosts. Neurol Neuroimmunol Neuroinflamm. 2021;8:e942.
Takaya J, Araki A, Mori K, Kaneko K. Usefulness of diffusion-weighted MRI in human herpesvirus-6 encephalitis. Acta Paediatr. 2007;96:137–8.
Schmidt-Hieber M, Engelhard D, Ullmann A, Ljungman P, Maertens J, Martino R et al. Central nervous system disorders after hematopoietic stem cell transplantation: a prospective study of the Infectious Diseases Working Party of EBMT. J Neurol. 2020;267:430–9.
Terao T, Matsuoka K, Fuji S, Kawamura S, Toya T, Doki N et al. Association between human herpesvirus-6 encephalitis and antiviral prophylaxis after allogeneic hematopoietic stem cell transplantation in the letermovir era. Bone Marrow Transpl. 2024;59:1224–31.
Handley G, Yepes A, Eliassen E, Dominguez G, Pasikhova Y, Klinkova O et al. Outcomes of haploidentical stem cell transplant recipients with HHV-6B reactivation. Open Forum Infect Dis. 2024;11:ofae564.
Ogata M, Uchida N, Fukuda T, Ikegame K, Kamimura T, Onizuka M et al. Clinical practice recommendations for the diagnosis and management of human herpesvirus-6B encephalitis after allogeneic hematopoietic stem cell transplantation: the Japan Society for Hematopoietic Cell Transplantation. Bone Marrow Transpl. 2020;55:1004–13.
Pöhlmann C, Schetelig J, Reuner U, Bornhäuser M, Illmer T, Kiani A et al. Cidofovir and foscarnet for treatment of human herpesvirus 6 encephalitis in a neutropenic stem cell transplant recipient. Clin Infect Dis. 2007;44:e118–120.
Agut H, Bonnafous P, Gautheret-Dejean A. Laboratory and clinical aspects of human herpesvirus 6 infections. Clin Microbiol Rev. 2015;28:313–35.
Kampouri E, Little JS, Crocchiolo R, Hill JA. Human herpesvirus-6, HHV-8 and parvovirus B19 after allogeneic hematopoietic cell transplant: the lesser-known viral complications. Curr Opin Infect Dis. 2024;37:245–53.
